Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Meiragtx Holdings Plc (NQ: MGTX )

8.070 +0.030 (+0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 153,864
Open 8.030
Bid (Size) 8.000 (90)
Ask (Size) 12.77 (1)
Prev. Close 8.040
Today's Range 7.680 - 8.350
52wk Range 4.770 - 11.57
Shares Outstanding 59,500,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga
MeiraGTx Announces the Presentation of Nine Posters at the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell Therapy 
From MeiraGTx
Via GlobeNewswire

Performance

YTD
+24.54%
+24.54%
1 Month
+30.16%
+30.16%
3 Month
+29.95%
+29.95%
6 Month
+39.14%
+39.14%
1 Year
+1.13%
+1.13%

More News

Read More
MeiraGTx Hldgs: Q1 Earnings Insights
Via Benzinga
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire
MeiraGTx Holdings's Return On Capital Employed Overview
Via Benzinga
MeiraGTx's Investigational Candidate Shows Improvement In Radiation Induced Dry Mouth Symptoms
Via Benzinga
MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial
Via Benzinga
MeiraGTx Hldgs: Q1 Earnings Insights
Via Benzinga
MeiraGTx Announces $60 Million Private Placement of Ordinary Shares
From MeiraGTx
Via GlobeNewswire
MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
From MeiraGTx
Via GlobeNewswire
MeiraGTx to Participate in Upcoming Investor Conferences
From MeiraGTx
Via GlobeNewswire
MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire
MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
From MeiraGTx
Via GlobeNewswire
MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022
From MeiraGTx
Via GlobeNewswire
MeiraGTx to Participate in Upcoming Investor Conferences
From MeiraGTx
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
MeiraGTx Reports Third Quarter 2022 Financial and Operational Results and Receives $25 Million Investment from Johnson & Johnson Innovation - JJDC, Inc.
From MeiraGTx
Via GlobeNewswire
MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress
From MeiraGTx
Via GlobeNewswire
Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of Investigational Gene Therapy Botaretigene Sparoparvovec (AAV-RPGR) and Sustained Vision Improvement in Patients with X-Linked Retinitis Pigmentosa (XLRP)
From MeiraGTx
Via GlobeNewswire
Kiora Pharma is Starting Human Trials of a Novel Treatment That Could Restore Vision In Patients With Inherited Blindness
Via Benzinga
MeiraGTx Reveals Interim Data From Phase 1 Trial Of Radiation-Induced Dry Mouth Symptom
Via Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
Via Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.